Women’s Health and Beauty Supplements Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 – 2030

The global Women’s Health and Beauty Supplements market size is expected to be worth around US$ 80.6 billion by 2030, according to a new report by Vision Research Reports.

The global Women’s Health and Beauty Supplements market size was valued at US$ 55.0 billion in 2020 and is anticipated to grow at a CAGR of 5.9% during forecast period 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38899

Report Coverage

Report Scope Details
Market Size US$ 80.6 Billion by 2030
Growth Rate CAGR of 5.9% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Product, Application, Age Group, Consumer Group, Sales Channel
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Amway; Herbalife International of America Inc.; GNC Holdings Inc.; The Nature’s Bounty Co.; Bayer AG; Garden of Life (Nestle); Suntory Holdings Limited; Taisho Pharmaceutical Co. Ltd.; Swisse Wellness Pty. Ltd.; Pharmavite LLC; Pfizer Inc.; Blackmores; Fancl Corporation; Asahi Group Holdings; Usana Health Sciences; Nu Skin Enterprises; By Health Co. Ltd; Revital Ltd.; The Himalaya Drug Company; Vita Life Sciences; Grape King Bio Ltd.; Standard Foods Corporation

Growth Factors

 Rising awareness levels about health and wellness along with the growing adoption of an active lifestyle are expected to boost product demand. Women are shifting their focus towards preventative healthcare and consuming vitamins and minerals. In addition, the COVID-19 pandemic has boosted the awareness of physical, mental, and emotional health and increased the implementation of self-care among consumers. This, in turn, has increased the adoption of health and beauty supplements. Consumers have started adopting vitamins, minerals, and botanicals to boost immunity.

By Product Analysis

The vitamins product segment accounted for the largest revenue share of over 37% in 2020 owing to the increased demand for immunity-boosting vitamins, such as vitamin C, D, and B, during the COVID-19 pandemic.

vitamin A is known to play a crucial role in the formation of organs, such as the lungs, kidneys, and heart of the fetus. However, the enzymes segment is expected to grow at the fastest CAGR over the forecast period due to the growing demand for Co-Enzyme Q10. Co-Enzyme Q10 is used widely in skin repair and cellular rejuvenation applications.

By Application Analysis

The women’s health application segment held the highest market share of more than 68% in 2020 and is also estimated to register the fastest CAGR during the forecast period. This growth is attributed to the availability of a variety of supplements for different conditions, such as prenatal, postnatal, bone & joint health, immune system, digestive system health, stress management, heart health, eye health, sexual health, and memory.

The increasing cases of vitamin, iron and other nutritional deficiencies among women are also supporting the segment growth. Moreover, a rise in the need for nutrients, mainly in prenatal, premenstrual, and perimenopause stages, is estimated to drive the segment growth. Consumption of immunity-boosting products has increased during the pandemic.

By Age Group Analysis

The age group 30 – 50 years segment held the highest market share of more than 42% in 2020. The high adoption of preventative medicines and the presence of a large consumer pool is major factor responsible for the high market share of this segment.

the above 70 years segment is estimated to register the fastest CAGR during the forecast period. It is attributed to the growing geriatric population. According to United Nations, the women population aged 80 years and above will reach 59% of the total population.

By Consumer Group Analysis

The others segment held the highest market share of 32.6% in 2020. A significant number of adolescent girls are reported to be underweight, and adequate intake of dietary supplements has been shown to improve their overall health.

the post-natal segment is estimated to register the fastest CAGR during the forecast period. Many women consume supplements to lose post-partum weight and maintain a healthy lifestyle.

women are looking for achieving adequate nutrient intake during the lactation phase. In addition, post-natal depression can be prevented by adequate nutrient intake. All the above-mentioned parameters are estimated to drive the post-natal segment growth during the forecast period.

By Sales Channel Analysis

The direct sales channel segment accounted for the largest revenue share of 35% in 2020. This is owing to the high consumer preference and trust for direct sales channels over other channels. Moreover, the direct sales channel offers lucrative discounts and flexible schemes.

the online segment is expected to grow at the fastest CAGR over the forecast period owing to a high preference for online channels and growing adoption of e-commerce platforms. There is a growing trend of personalization of vitamins and other nutrients.

By Regional Analysis

Asia Pacific accounted for the highest revenue share of 38.9% in 2020, due to the increased awareness and adoption of women’s health and beauty supplements, and high disposable income & number of working women.

Middle East & Africa is anticipated to register the fastest CAGR during the forecast period. The increasing number of instances of nutritional deficiencies, the growing concerns about lifestyle disorders, and rising product awareness are estimated to drive the regional markets.

Key Players

  • Amway
  • Herbalife International of America, Inc.
  • GNC Holdings, Inc.
  • The Nature’s Bounty Co.
  • Bayer AG; Garden of Life (Nestle)
  • Suntory Holdings Ltd.
  • Taisho Pharmaceutical Co. Ltd.
  • Swisse Wellness Pty. Ltd.
  • Pharmavite LLC
  • Pfizer, Inc.
  • Blackmores
  • Fancl Corp.
  • Asahi Group Holdings
  • Usana Health Sciences
  • Nu Skin Enterprises
  • BY-Health Co. Ltd.
  • Revital Ltd.
  • The Himalaya Drug Company
  • Vita Life Sciences
  • Grape King Bio Ltd.
  • Standard Foods Corp.

Market Segmentation

  • By Product
    • Vitamins
    • Mineral
    • Enzymes
    • Botanicals
    • Proteins
    • Omega-3
    • Probiotics
    • Others
  • By Application
    • Beauty
    • Women’s Health
      • Skin Care
      • Nail Care
      • Hair Care
      • Others
  • By Age Group
    • Age 15 – 30
    • Age 31 – 50
    • Age 51 – 70
    • Above 70 years
  • By Consumer Group
    • Prenatal
    • Postnatal
    • PMS
    • Perimenopause
    • Postmenopause
    • Others
  • By Sales Channel
    • Online
    • Direct Sales
    • Pharmacies/Drug Stores
    • Other offline channels
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Russia
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
      • Taiwan
      • Malaysia
      • Thailand
    • Latin America
      • Mexico
      • Brazil
      • Argentina
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38899

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Women’s Health and Beauty Supplements Market, By Product

7.1.  Women’s Health and Beauty Supplements Market, by Product, 2021-2030

7.1.1.    Vitamins

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Mineral

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Enzymes

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Botanicals

7.1.4.1.        Market Revenue and Forecast (2017-2030)

7.1.5.    Proteins

7.1.5.1.        Market Revenue and Forecast (2017-2030)

7.1.6.    Omega-3

7.1.6.1.        Market Revenue and Forecast (2017-2030)

7.1.7.    Probiotics

7.1.7.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Women’s Health and Beauty Supplements Market, By Application

8.1.  Women’s Health and Beauty Supplements Market, by Application, 2021-2030

8.1.1.    Beauty

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Women’s Health

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Women’s Health and Beauty Supplements Market, By Age-Group

9.1.  Women’s Health and Beauty Supplements Market, by Age-Group, 2021-2030

9.1.1.    Age 15 – 30

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Age 31 – 50

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Age 51 – 70

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Above 70 years

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Women’s Health and Beauty Supplements Market, By Consumer Group

10.1.        Women’s Health and Beauty Supplements Market, by Consumer Group, 2021-2030

10.1.1.  Prenatal

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Postnatal

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  PMS

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Perimenopause

10.1.4.1.      Market Revenue and Forecast (2017-2030)

10.1.5.  Postmenopause

10.1.5.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Women’s Health and Beauty Supplements Market, By Sales Channel

11.1.        Women’s Health and Beauty Supplements Market, by Sales Channel, 2021-2030

11.1.1.  Online

11.1.1.1.      Market Revenue and Forecast (2017-2030)

11.1.2.  Direct Sales

11.1.2.1.      Market Revenue and Forecast (2017-2030)

11.1.3.  Pharmacies/Drug Stores

11.1.3.1.      Market Revenue and Forecast (2017-2030)

11.1.4.  Other offline channels

11.1.4.1.      Market Revenue and Forecast (2017-2030)

Chapter 12.      Global Women’s Health and Beauty Supplements  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, by Product (2017-2030)

12.1.2.  Market Revenue and Forecast, by Application (2017-2030)

12.1.3.  Market Revenue and Forecast, by Age-Group (2017-2030)

12.1.4.  Market Revenue and Forecast, by Consumer Group (2017-2030)

12.1.5.  Market Revenue and Forecast, by Sales Channel (2017-2030)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, by Product (2017-2030)

12.1.6.2.      Market Revenue and Forecast, by Application (2017-2030)

12.1.6.3.      Market Revenue and Forecast, by Age-Group (2017-2030)

12.1.6.4.      Market Revenue and Forecast, by Consumer Group (2017-2030)

12.1.6.5.      Market Revenue and Forecast, by Sales Channel (2017-2030)

12.1.7.  Rest of North America

12.1.7.1.      Market Revenue and Forecast, by Product (2017-2030)

12.1.7.2.      Market Revenue and Forecast, by Application (2017-2030)

12.1.7.3.      Market Revenue and Forecast, by Age-Group (2017-2030)

12.1.7.4.      Market Revenue and Forecast, by Consumer Group (2017-2030)

12.1.7.5.      Market Revenue and Forecast, by Sales Channel (2017-2030)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, by Product (2017-2030)

12.2.2.  Market Revenue and Forecast, by Application (2017-2030)

12.2.3.  Market Revenue and Forecast, by Age-Group (2017-2030)

12.2.4.  Market Revenue and Forecast, by Consumer Group (2017-2030)

12.2.5.  Market Revenue and Forecast, by Sales Channel (2017-2030)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, by Product (2017-2030)

12.2.6.2.      Market Revenue and Forecast, by Application (2017-2030)

12.2.6.3.      Market Revenue and Forecast, by Age-Group (2017-2030)

12.2.6.4.      Market Revenue and Forecast, by Consumer Group (2017-2030)

12.2.6.5.      Market Revenue and Forecast, by Sales Channel (2017-2030)

12.2.7.  Germany

12.2.7.1.      Market Revenue and Forecast, by Product (2017-2030)

12.2.7.2.      Market Revenue and Forecast, by Application (2017-2030)

12.2.7.3.      Market Revenue and Forecast, by Age-Group (2017-2030)

12.2.7.4.      Market Revenue and Forecast, by Consumer Group (2017-2030)

12.2.7.5.      Market Revenue and Forecast, by Sales Channel (2017-2030)

12.2.8.  France

12.2.8.1.      Market Revenue and Forecast, by Product (2017-2030)

12.2.8.2.      Market Revenue and Forecast, by Application (2017-2030)

12.2.8.3.      Market Revenue and Forecast, by Age-Group (2017-2030)

12.2.8.4.      Market Revenue and Forecast, by Consumer Group (2017-2030)

12.2.8.5.      Market Revenue and Forecast, by Sales Channel (2017-2030)

12.2.9.  Rest of Europe

12.2.9.1.      Market Revenue and Forecast, by Product (2017-2030)

12.2.9.2.      Market Revenue and Forecast, by Application (2017-2030)

12.2.9.3.      Market Revenue and Forecast, by Age-Group (2017-2030)

12.2.9.4.      Market Revenue and Forecast, by Consumer Group (2017-2030)

12.2.9.5.      Market Revenue and Forecast, by Sales Channel (2017-2030)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, by Product (2017-2030)

12.3.2.  Market Revenue and Forecast, by Application (2017-2030)

12.3.3.  Market Revenue and Forecast, by Age-Group (2017-2030)

12.3.4.  Market Revenue and Forecast, by Consumer Group (2017-2030)

12.3.5.  Market Revenue and Forecast, by Sales Channel (2017-2030)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, by Product (2017-2030)

12.3.6.2.      Market Revenue and Forecast, by Application (2017-2030)

12.3.6.3.      Market Revenue and Forecast, by Age-Group (2017-2030)

12.3.6.4.      Market Revenue and Forecast, by Consumer Group (2017-2030)

12.3.6.5.      Market Revenue and Forecast, by Sales Channel (2017-2030)

12.3.7.  China

12.3.7.1.      Market Revenue and Forecast, by Product (2017-2030)

12.3.7.2.      Market Revenue and Forecast, by Application (2017-2030)

12.3.7.3.      Market Revenue and Forecast, by Age-Group (2017-2030)

12.3.7.4.      Market Revenue and Forecast, by Consumer Group (2017-2030)

12.3.7.5.      Market Revenue and Forecast, by Sales Channel (2017-2030)

12.3.8.  Japan

12.3.8.1.      Market Revenue and Forecast, by Product (2017-2030)

12.3.8.2.      Market Revenue and Forecast, by Application (2017-2030)

12.3.8.3.      Market Revenue and Forecast, by Age-Group (2017-2030)

12.3.8.4.      Market Revenue and Forecast, by Consumer Group (2017-2030)

12.3.8.5.      Market Revenue and Forecast, by Sales Channel (2017-2030)

12.3.9.  Rest of APAC

12.3.9.1.      Market Revenue and Forecast, by Product (2017-2030)

12.3.9.2.      Market Revenue and Forecast, by Application (2017-2030)

12.3.9.3.      Market Revenue and Forecast, by Age-Group (2017-2030)

12.3.9.4.      Market Revenue and Forecast, by Consumer Group (2017-2030)

12.3.9.5.      Market Revenue and Forecast, by Sales Channel (2017-2030)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, by Product (2017-2030)

12.4.2.  Market Revenue and Forecast, by Application (2017-2030)

12.4.3.  Market Revenue and Forecast, by Age-Group (2017-2030)

12.4.4.  Market Revenue and Forecast, by Consumer Group (2017-2030)

12.4.5.  Market Revenue and Forecast, by Sales Channel (2017-2030)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, by Product (2017-2030)

12.4.6.2.      Market Revenue and Forecast, by Application (2017-2030)

12.4.6.3.      Market Revenue and Forecast, by Age-Group (2017-2030)

12.4.6.4.      Market Revenue and Forecast, by Consumer Group (2017-2030)

12.4.6.5.      Market Revenue and Forecast, by Sales Channel (2017-2030)

12.4.7.  North Africa

12.4.7.1.      Market Revenue and Forecast, by Product (2017-2030)

12.4.7.2.      Market Revenue and Forecast, by Application (2017-2030)

12.4.7.3.      Market Revenue and Forecast, by Age-Group (2017-2030)

12.4.7.4.      Market Revenue and Forecast, by Consumer Group (2017-2030)

12.4.7.5.      Market Revenue and Forecast, by Sales Channel (2017-2030)

12.4.8.  South Africa

12.4.8.1.      Market Revenue and Forecast, by Product (2017-2030)

12.4.8.2.      Market Revenue and Forecast, by Application (2017-2030)

12.4.8.3.      Market Revenue and Forecast, by Age-Group (2017-2030)

12.4.8.4.      Market Revenue and Forecast, by Consumer Group (2017-2030)

12.4.8.5.      Market Revenue and Forecast, by Sales Channel (2017-2030)

12.4.9.  Rest of MEA

12.4.9.1.      Market Revenue and Forecast, by Product (2017-2030)

12.4.9.2.      Market Revenue and Forecast, by Application (2017-2030)

12.4.9.3.      Market Revenue and Forecast, by Age-Group (2017-2030)

12.4.9.4.      Market Revenue and Forecast, by Consumer Group (2017-2030)

12.4.9.5.      Market Revenue and Forecast, by Sales Channel (2017-2030)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, by Product (2017-2030)

12.5.2.  Market Revenue and Forecast, by Application (2017-2030)

12.5.3.  Market Revenue and Forecast, by Age-Group (2017-2030)

12.5.4.  Market Revenue and Forecast, by Consumer Group (2017-2030)

12.5.5.  Market Revenue and Forecast, by Sales Channel (2017-2030)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, by Product (2017-2030)

12.5.6.2.      Market Revenue and Forecast, by Application (2017-2030)

12.5.6.3.      Market Revenue and Forecast, by Age-Group (2017-2030)

12.5.6.4.      Market Revenue and Forecast, by Consumer Group (2017-2030)

12.5.6.5.      Market Revenue and Forecast, by Sales Channel (2017-2030)

12.5.7.  Rest of LATAM

12.5.7.1.      Market Revenue and Forecast, by Product (2017-2030)

12.5.7.2.      Market Revenue and Forecast, by Application (2017-2030)

12.5.7.3.      Market Revenue and Forecast, by Age-Group (2017-2030)

12.5.7.4.      Market Revenue and Forecast, by Consumer Group (2017-2030)

12.5.7.5.      Market Revenue and Forecast, by Sales Channel (2017-2030)

Chapter 13.  Company Profiles

13.1.              Amway

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              Herbalife International of America, Inc.

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              GNC Holdings, Inc.

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              The Nature’s Bounty Co.

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              Bayer AG; Garden of Life (Nestle)

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Suntory Holdings Ltd.

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              Taisho Pharmaceutical Co. Ltd.

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Swisse Wellness Pty. Ltd.

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              Pharmavite LLC

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           Pfizer, Inc.

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38899

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com